Cabozantinib impurity 1DYH
|
|
Cabozantinib impurity 1DYH 속성
- 밀도
- 1.36±0.1 g/cm3(Predicted)
- 산도 계수 (pKa)
- 13.86±0.70(Predicted)
안전
Cabozantinib impurity 1DYH C화학적 특성, 용도, 생산
용도
Cabozantinib N-oxide is a impurity of Cabozantinib (X745500), a medication used to treat medullary thyroid cancer. As well, it can be used in biological study. Computational network biological approach based on pathway cross-talk inhibition identified new synergistic drug combinations using raloxifene and cabozantinib for treatment of human breast cancer in xenograft mouse model. Potent c-MET inhibitor.Cabozantinib impurity 1DYH 준비 용품 및 원자재
원자재
준비 용품
Cabozantinib impurity 1DYH 공급 업체
글로벌( 28)공급 업체
공급자 | 전화 | 이메일 | 국가 | 제품 수 | 이점 |
---|---|---|---|---|---|
S.Z. PhyStandard Bio-Tech. Co., Ltd. | 0755-4000505016 13380397412 |
3001272453@qq.com | China | 5059 | 50 |
Beijing Comparison Pharmaceutical Technology Co., Ltd | 010-010-52878169 15801002657 |
sales@bjcomparison.com | China | 4791 | 58 |
Shanghai Kewel Chemical Co., Ltd. | 021-64609169 18901607656 |
greensnown@163.com | China | 9911 | 50 |
Zhaoqing Wanwei New Material Technology Co., Ltd. | 0755-1328880-4488 13068786899 |
13288804488@163.com | China | 625 | 58 |
Shenzhen Botel Biotechnology Co. Ltd. | 13316949107 13316968096 |
1979313431@qq.com | China | 8516 | 58 |
Wuhan chuanghao Biotechnology Co., Ltd | 13361917963 |
876725023@qq.com | China | 295 | 58 |
Wuxi Helen Biotechnology Co., Ltd., | 0510-85629785 18013409632 |
sales@reading-chemicals.com | China | 14081 | 58 |
Foshan Treasure Biotechnology Co., Ltd | 0757-85921206 18520245316 |
2329783215@qq.com | China | 12664 | 58 |
QUALITY CONTROL SOLUTIONS LTD. | 13670046396 |
ORDERS@QCSRM.COM | China | 18865 | 58 |
Nanjing Shanyao Kangcheng biomedical Co., Ltd. | 15722982350 |
1170703875@qq.com | China | 518 | 58 |
Cabozantinib impurity 1DYH 관련 검색:
Cabozantinib Impurity EXA
1-(4-Fluorophenylcarbamoyl)cyclopropanecarboxylic acid
Cyclopropanecarboxylic acid, 1-[[[4-[[7-methoxy-6-(sulfooxy)-4-quinolinyl]oxy]phenyl]amino]carbonyl]-
1,1-Cyclopropanedicarboxamide,N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-phenyl-
Quinoline, 6,7-dimethoxy-4-(4-nitrophenoxy)-
Cyclopropanecarboxylic acid, 1-[(phenylaMino)carbonyl]-
Cabozantinib Malate
1,1-Cyclopropanedicarboxamide, N,N'-bis[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-
Cyclopropanecarboxylic acid, 1-[[(2-fluorophenyl)amino]carbonyl]-
Sunitinib
Lapatinib
Cabozantinib
LOXO-101
Dasatinib
Cabozantinib Impurity DM
1,3-Dioxane-4,6-dione, 5-[[(3,4-diMethoxyphenyl)aMino]Methylene]-2,2-diMethyl-
N,N'-Bis(4-hydroxyphenyl)hydrazine
Cabozantinib impurity DX2